Novartis AG (NVS)

NYQ – Real Time Price. Currency in USD

152.66

-1.95 (-1.26%)

Market open: Aug 12, 2026, 10:45 AM EDT

155.85

+1.24 (0.80%)

Previous after-hours: Aug 11, 2026, 7:58 PM EDT

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

54.81B

50.29B

45.60B

42.29B

Cost of goods sold

-13.69B

-12.81B

-12.62B

-11.45B

Gross Profit

41.12B

37.48B

32.98B

30.84B

Operating expenses (excl. COGS)

-24.05B

-22.06B

-21.08B

-20.45B

Operating Income

17.07B

15.42B

11.91B

10.39B

Non-operating income, total

-626M

-1.75B

-2.74B

-3.18B

Pretax income

16.45B

13.67B

9.17B

7.20B

Equity in earnings

-12M

-38M

-13M

-11M

Taxes

-2.40B

-1.70B

-553M

-1.13B

Non-controlling/minority interest

17M

-4M

After tax other income/expense

Net income before discontinued operations

14.06B

11.93B

8.60B

6.06B

Discontinued operations

6.30B

908M

Net income

14.06B

11.93B

14.90B

6.97B

Dilution adjustment

Preferred dividends

Novartis AG (NVS)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Novartis AG (NVS)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Novartis AG (NVS)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Novartis AG (NVS)

Income Statement (Annual)

Income Statement (Annual)